English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Implication for health policy/practice/research/medical education: Antiphospholipid syndrome (APS) is being increasingly recognized as an important cause of kidney injury due to thrombosis at any location within the renal vasculature. The term antiphospholipid syndrome nephropathy (APSN) refers to the kidney damage caused by vascular lesions in the glomeruli, arterioles and/ or interlobular arteries in patients with antiphospholipid antibodies. APSN manifests with hypertension, acute and/or chronic kidney failure, and often a lowgrade proteinuria.

Hypertension and renal failure with right arm pulse weakness in a 65 years old man